Utility of Laboratory Testing for Children With Seizure in Emergency Department

This study has been completed.
Information provided by:
Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier:
First received: May 12, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted

Objective: To evaluate the predisposing factors associated with abnormal laboratory findings in patients who came to the emergency room due to a first seizure.

Methods: Patients were divided into separate groups based on normal and abnormal laboratory results for sodium, potassium, calcium, and glucose. The difference in age, gender, whether this was the first attack, whether there was fever, whether there were gastrointestinal symptoms, the duration and pattern of the seizure, and whether there was a seizure at the emergency department, were evaluated.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Taipei Medical University WanFang Hospital:

Estimated Enrollment: 500
Study Start Date: October 2009
Study Completion Date: April 2010
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
500 patients who come to wanfang hospital due to seizure

Inclusion Criteria:

  • Age: less than 18 years old
  • The patient came to emergency department due to seizure
  • The patient received blood sampling including serum sodium, potassium, calcium and glucose.

Exclusion Criteria:

  • The patient came to the outpatient department.
  • The patient did not received blood sampling at emergency room.
  • The seizure occurred after admission.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01123746

Taipei Medical University-WanFang Hospital
Taipei, Taiwan, 116
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
Principal Investigator: Hsiao-Feng Chou, M.D. Pediatrics department, Wanfang hospital
  More Information

Responsible Party: Chou Hsiao-Feng, Department of Pediatrics, Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier: NCT01123746     History of Changes
Other Study ID Numbers: 98088 
Study First Received: May 12, 2010
Last Updated: May 12, 2010

Keywords provided by Taipei Medical University WanFang Hospital:
risk factor

Additional relevant MeSH terms:
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on January 19, 2017